Iktos

Artificial Intelligence for new drug design

placeParis, Ile De France, France calendar_todayFounded 2016 groups55 employees language iktos.ai

Innovation

1 patent family — focus: Physics & computing; filing pace active. Cited 13 times.

YearFilings
20241

Investor mix

3 investors on record; lead investors include M Ventures, Debiopharm.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%
Coming soon